Literature DB >> 18068630

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.

Chen Zhao1, Jordan Blum, Alan Chen, Hyog Young Kwon, Seung Hye Jung, J Michael Cook, Anand Lagoo, Tannishtha Reya.   

Abstract

A key characteristic of stem cells and cancer cells is their ability to self-renew. To test if Wnt signaling can regulate the self-renewal of both stem cells and cancer cells in the hematopoietic system, we developed mice that lack beta-catenin in their hematopoietic cells. Here we show that beta-catenin-deficient mice can form HSCs, but that these cells are deficient in long-term growth and maintenance. Moreover, beta-catenin deletion causes a profound reduction in the ability of mice to develop BCR-ABL-induced chronic myelogenous leukemia (CML), while allowing progression of acute lymphocytic leukemia (ALL). These studies demonstrate that Wnt signaling is required for the self-renewal of normal and neoplastic stem cells in the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068630      PMCID: PMC2262869          DOI: 10.1016/j.ccr.2007.11.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  58 in total

1.  Deletion of beta-catenin impairs T cell development.

Authors:  Youyuan Xu; Daliya Banerjee; Joerg Huelsken; Walter Birchmeier; Jyoti Misra Sen
Journal:  Nat Immunol       Date:  2003-11-09       Impact factor: 25.606

2.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

3.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

4.  Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.

Authors:  A S Tsukamoto; R Grosschedl; R C Guzman; T Parslow; H E Varmus
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

5.  Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.

Authors:  Xiaomin Zheng; Tim Beissert; Natasa Kukoc-Zivojnov; Elena Puccetti; Joachim Altschmied; Corinna Strolz; Simone Boehrer; Hilal Gul; Orinta Schneider; Oliver Gerhard Ottmann; Dieter Hoelzer; Reinhard Henschler; Martin Ruthardt
Journal:  Blood       Date:  2004-01-22       Impact factor: 22.113

6.  Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.

Authors:  Elena Almarza; José Carlos Segovia; Guillermo Guenechea; Susana G Gómez; Angel Ramírez; Juan Antonio Bueren
Journal:  Exp Hematol       Date:  2004-04       Impact factor: 3.084

7.  Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.

Authors:  Yiguo Hu; Yuhua Liu; Shawn Pelletier; Elisabeth Buchdunger; Markus Warmuth; Doriano Fabbro; Michael Hallek; Richard A Van Etten; Shaoguang Li
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

8.  Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.

Authors:  Carsten Müller-Tidow; Björn Steffen; Thomas Cauvet; Lara Tickenbrock; Ping Ji; Sven Diederichs; Bülent Sargin; Gabriele Köhler; Matthias Stelljes; Elena Puccetti; Martin Ruthardt; Sven deVos; Scott W Hiebert; H Phillip Koeffler; Wolfgang E Berdel; Hubert Serve
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility.

Authors:  Anna Cattelino; Stefan Liebner; Radiosa Gallini; Adriana Zanetti; Giovanna Balconi; Alessandro Corsi; Paolo Bianco; Hartwig Wolburg; Robert Moore; Boussadia Oreda; Rolf Kemler; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2003-09-15       Impact factor: 10.539

10.  Beta-catenin is dispensable for hematopoiesis and lymphopoiesis.

Authors:  Monica Cobas; Anne Wilson; Bettina Ernst; Stéphane J C Mancini; H Robson MacDonald; Rolf Kemler; Freddy Radtke
Journal:  J Exp Med       Date:  2004-01-12       Impact factor: 14.307

View more
  262 in total

Review 1.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  Prostate cancer stem cell biology.

Authors:  C Yu; Z Yao; Y Jiang; E T Keller
Journal:  Minerva Urol Nefrol       Date:  2012-03       Impact factor: 3.720

3.  Non-cell-autonomous hedgehog signaling promotes murine B lymphopoiesis from hematopoietic progenitors.

Authors:  Christopher L Cooper; Richard R Hardy; Michael Reth; Stephen Desiderio
Journal:  Blood       Date:  2012-04-18       Impact factor: 22.113

4.  β-Arrestin2 mediates the initiation and progression of myeloid leukemia.

Authors:  Mark Fereshteh; Takahiro Ito; Jeffrey J Kovacs; Chen Zhao; Hyog Young Kwon; Valerie Tornini; Takaaki Konuma; Minyong Chen; Robert J Lefkowitz; Tannishtha Reya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

5.  PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.

Authors:  Paolo Neviani; Jason G Harb; Joshua J Oaks; Ramasamy Santhanam; Christopher J Walker; Justin J Ellis; Gregory Ferenchak; Adrienne M Dorrance; Carolyn A Paisie; Anna M Eiring; Yihui Ma; Hsiaoyin C Mao; Bin Zhang; Mark Wunderlich; Philippa C May; Chaode Sun; Sahar A Saddoughi; Jacek Bielawski; William Blum; Rebecca B Klisovic; Janelle A Solt; John C Byrd; Stefano Volinia; Jorge Cortes; Claudia S Huettner; Steffen Koschmieder; Tessa L Holyoake; Steven Devine; Michael A Caligiuri; Carlo M Croce; Ramiro Garzon; Besim Ogretmen; Ralph B Arlinghaus; Ching-Shih Chen; Robert Bittman; Peter Hokland; Denis-Claude Roy; Dragana Milojkovic; Jane Apperley; John M Goldman; Alistair Reid; James C Mulloy; Ravi Bhatia; Guido Marcucci; Danilo Perrotti
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

6.  Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.

Authors:  Annelie E Abrahamsson; Ifat Geron; Jason Gotlib; Kim-Hien T Dao; Charlene F Barroga; Isabel G Newton; Francis J Giles; Jeffrey Durocher; Remi S Creusot; Mobin Karimi; Carol Jones; James L Zehnder; Armand Keating; Robert S Negrin; Irving L Weissman; Catriona H M Jamieson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 7.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 8.  Cancer stem cells: relevance to SCT.

Authors:  T Lin; R J Jones; W Matsui
Journal:  Bone Marrow Transplant       Date:  2009-02-23       Impact factor: 5.483

9.  Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.

Authors:  Gabriel J Sandoval; Daniel B Graham; Grzegorz B Gmyrek; Holly M Akilesh; Keiko Fujikawa; Benedicte Sammut; Deepta Bhattacharya; Shuba Srivatsan; Alfred Kim; Andrey S Shaw; Katherine Yang-Iott; Craig H Bassing; Eric Duncavage; Ramnik J Xavier; Wojciech Swat
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

10.  Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Exp Hematol       Date:  2008-10-25       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.